Cargando…
Biomarkers of Fabry Nephropathy: Review and Future Perspective
Progressive nephropathy is one of the main features of Fabry disease, which largely contributes to the overall morbidity and mortality burden of the disease. Due to the lack of specific biomarkers, the heterogeneity of the disease, and unspecific symptoms, diagnosis is often delayed. Clinical presen...
Autores principales: | Levstek, Tina, Vujkovac, Bojan, Trebusak Podkrajsek, Katarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564978/ https://www.ncbi.nlm.nih.gov/pubmed/32962051 http://dx.doi.org/10.3390/genes11091091 |
Ejemplares similares
-
Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy
por: Levstek, Tina, et al.
Publicado: (2023) -
Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
por: Levstek, Tina, et al.
Publicado: (2021) -
Telomere Attrition in Chronic Kidney Diseases
por: Levstek, Tina, et al.
Publicado: (2023) -
Telomere Attrition in Neurodegenerative Disorders
por: Levstek, Tina, et al.
Publicado: (2020) -
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels
por: Levstek, Tina, et al.
Publicado: (2022)